AGLE - Aeglea Bio Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

AGLE is currently covered by 3 analysts with an average price target of $58.58. This is a potential upside of $30.98 (112.25%) from yesterday's end of day stock price of $27.6.

Aeglea Bio Therapeutics's activity chart (see below) currently has 7 price targets and 17 ratings on display. The stock rating distribution of AGLE is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.17% with an average time for these price targets to be met of 237.17 days.

Highest price target for AGLE is $25, Lowest price target is $12.5, average price target is $58.58.

Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 16-Aug-2023. First documented stock forecast 02-May-2016.

Best performing analysts who are covering AGLE - Aeglea Bio Therapeutics:

Edward White Yanan Zhu Gil Blum Edward Tenthoff Chad Messer Matthew Luchini

Currently out of the existing stock ratings of AGLE, 4 are a BUY (50%), 4 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

12.5

$-15.1 (-54.71%)

6 months 7 days ago

2/2 (100%)

$0.95 (8.23%)

9

Hold

25

$-2.6 (-9.42%)

25

11 months 20 days ago

2/2 (100%)

$15.15 (153.81%)

238

Hold

25

1 years 3 months 27 days ago

1/4 (25%)

$6.75 (36.99%)

151

Buy

11

1 years 8 months 20 days ago

2/2 (100%)

$3.33 (40.64%)

1025

Buy

350

3 years 9 months 16 days ago

0/4 (0%)

$150 (75.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AGLE (Aeglea Bio Therapeutics) average time for price targets to be met?

On average it took 237.17 days on average for the stock forecasts to be realized with a an average price target met ratio 54.17

Which analyst has the current highest performing score on AGLE (Aeglea Bio Therapeutics) with a proven track record?

EDWARD WHITE

Which analyst has the current lower performing score on AGLE (Aeglea Bio Therapeutics) with a proven track record?

MATTHEW LUCHINI

Which analyst has the most public recommendations on AGLE (Aeglea Bio Therapeutics)?

Edward White works at HC WAINWRIGHT and has 16 price targets and 11 ratings on AGLE

Which analyst is the currently most bullish on AGLE (Aeglea Bio Therapeutics)?

Matthew Luchini with highest potential upside - $0

Which analyst is the currently most reserved on AGLE (Aeglea Bio Therapeutics)?

Yanan Zhu with lowest potential downside - -$15.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?